Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide
- 1 April 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (7), 1182-1188
- https://doi.org/10.1016/0002-9149(83)90366-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Metabolite cumulation during long-term oral encainide administrationClinical Pharmacology & Therapeutics, 1982
- Malignant ventricular tachyarrhythmias associated with the use of encainideAmerican Heart Journal, 1981
- Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.Circulation, 1981
- Antiarrhythmic efficacy of encainide and quinidine: Validation of a model for drug assessmentThe American Journal of Cardiology, 1981
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agentThe American Journal of Cardiology, 1979
- Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drugEuropean Journal of Clinical Pharmacology, 1979
- Analysis of Encainide in Plasma by Radioimmunoassay and High Pressure Liquid ChromatographyTherapeutic Drug Monitoring, 1979